======= SLC40A1 ======= == Gene Information == * **Official Symbol**: SLC40A1 * **Official Name**: solute carrier family 40 member 1 * **Aliases and Previous Symbols**: N/A * **Entrez ID**: [[https://www.ncbi.nlm.nih.gov/gene/?term=30061|30061]] * **UniProt**: [[https://www.uniprot.org/uniprot/Q9NP59|Q9NP59]] * **Interactions**: [[https://thebiogrid.org/search.php?search=SLC40A1&organism=9606|BioGRID]] * **PubMed articles**: [[https://www.ncbi.nlm.nih.gov/pubmed/?term=gene%20SLC40A1|Open PubMed]] * **OMIM**: [[https://omim.org/entry/604653|Open OMIM]] == Function Summary == * **Entrez Summary**: The protein encoded by this gene is a cell membrane protein that may be involved in iron export from duodenal epithelial cells. Defects in this gene are a cause of hemochromatosis type 4 (HFE4). [provided by RefSeq, Jul 2008]. * **UniProt Summary**: May be involved in iron export from duodenal epithelial cell and also in transfer of iron between maternal and fetal circulation. Mediates iron efflux in the presence of a ferroxidase (hephaestin and/or ceruloplasmin). |FPN1| |spleen trabecula formation| |iron ion export across plasma membrane| |regulation of transcription from RNA polymerase II promoter in response to iron| |ferrous iron transmembrane transporter activity| |iron ion transmembrane transporter activity| |multicellular organismal iron ion homeostasis| |cellular response to iron ion| |iron ion transmembrane transport| |trabecula formation| |response to iron ion| |spleen development| |export across plasma membrane| |peptide hormone binding| |trabecula morphogenesis| |lymphocyte homeostasis| |cellular iron ion homeostasis| |leukocyte homeostasis| |iron ion transport| |iron ion homeostasis| |endothelium development| |cellular transition metal ion homeostasis| |synaptic vesicle| |transition metal ion transport| |transition metal ion homeostasis| |cellular response to metal ion| |basolateral plasma membrane| |homeostasis of number of cells| |cellular response to inorganic substance| |divalent inorganic cation transport| |multicellular organismal homeostasis| |response to metal ion| |response to inorganic substance| |cellular metal ion homeostasis| |inorganic cation transmembrane transport| |hematopoietic or lymphoid organ development| |cation transmembrane transport| |metal ion homeostasis| |cellular cation homeostasis| |metal ion transport| |cellular ion homeostasis| |inorganic ion transmembrane transport| |immune system development| |cation homeostasis| |inorganic ion homeostasis| |cellular chemical homeostasis| |ion homeostasis| |cation transport| |negative regulation of apoptotic process| |anatomical structure formation involved in morphogenesis| |cellular homeostasis| |negative regulation of programmed cell death| |ion transmembrane transport| |animal organ morphogenesis| |negative regulation of cell death| |export from cell| |identical protein binding| |chemical homeostasis| |epithelium development| |positive regulation of transcription by RNA polymerase II| |transmembrane transport| |ion transport| |integral component of plasma membrane| |regulation of apoptotic process| |positive regulation of transcription, DNA-templated| |regulation of programmed cell death| |positive regulation of nucleic acid-templated transcription| |positive regulation of RNA biosynthetic process| |homeostatic process| |regulation of cell death| |positive regulation of RNA metabolic process| |tissue development| |positive regulation of nucleobase-containing compound metabolic process| |positive regulation of macromolecule biosynthetic process| |positive regulation of cellular biosynthetic process| |positive regulation of gene expression| |positive regulation of biosynthetic process| \\ === CRISPR Data === ^Screen^Score^ |[[:results:exp217|Mdivi-1 15μM R05 exp217]]|-2.37| |[[:results:exp510|Nicotine 3000μM R08 exp510]]|-1.91| |[[:results:exp170|Metformin 100 to 150μM on day4 R04 exp170]]|-1.77| |[[:results:exp446|4-Nitroquinoline-1-oxide 0.5μM R08 exp446]]|-1.73| |[[:results:exp310|2-Methoxyestradiol 0.55μM R07 exp310]]|-1.72| |[[:results:exp61|YM155 0.0002μM R01 exp61]]|1.71| |[[:results:exp501|Methotrexate 0.01μM R08 exp501]]|1.77| |[[:results:exp144|PFI-3 10μM R03 exp144]]|1.79| |[[:results:exp25|Oligomycin-A 2μM R00 exp25]]|1.83| No correlation found to any other genes in chemogenomics. Global Fraction of Cell Lines Where Essential: 0/739 ^Tissue^Fraction Of Cell Lines Where Essential^ |1290807.0|0/1| |909776.0|0/1| |bile duct|0/28| |blood|0/28| |bone|0/26| |breast|0/33| |central nervous system|0/56| |cervix|0/4| |colorectal|0/17| |esophagus|0/13| |fibroblast|0/1| |gastric|0/16| |kidney|0/21| |liver|0/20| |lung|0/75| |lymphocyte|0/16| |ovary|0/26| |pancreas|0/24| |peripheral nervous system|0/16| |plasma cell|0/15| |prostate|0/1| |skin|0/24| |soft tissue|0/9| |thyroid|0/2| |upper aerodigestive|0/22| |urinary tract|0/29| |uterus|0/5| == Essentiality in NALM6 == * **Essentiality Rank**: 9709 * **Expression level (log2 read counts)**: -7.68 {{:chemogenomics:nalm6 dist.png?nolink |}}